AMER HEART ASSOC

• 

  Publisher Of

  • Acute profound thrombocytopenia after c7E3 fab therapy - Response.  Circulation.  96:3810-3810. 1997
  • Abciximab readministration for coronary interventions: Is it safe?.  Circulation.  96:901-901. 1997
  • Abciximab reduces risk of unplanned coronary stent deployment: Epilog trial results.  Circulation.  96:906-906. 1997
  • Acute myocardial beta-adrenergic receptor desensitization during cardiopulmonary bypass for cardiac valve surgery.  Circulation.  96:2844-2844. 1997
  • Assessing the cost-effectiveness of newer therapies in non-ST elevation acute coronary syndrome patients.  Circulation.  96:1011-1011. 1997
  • Attenuation of pressure overload hypertrophy in transgenic mice expressing an inhibitor of G(q)-coupled signaling.  Circulation.  96:1635-1635. 1997
  • Cardiac surgery outcomes in 3,220 octogenarians: Results from the National Cardiovascular Network.  Circulation.  96:59-59. 1997
  • Coronary stent costs completely recouped in six months.  Circulation.  96:2551-2551. 1997
  • Does adenosine in conjunction with thrombolysis reduce infarct size? Results from the controlled, randomized AMISTAD trial.  Circulation.  96:1144-1144. 1997
  • Durable inhibition of ischemic complications by abciximab during percutaneous coronary revascularization: One-year results of the EPILOG trial.  Circulation.  96:902-902. 1997
  • Enhanced anti-platelet therapy is more important than choice of thrombolytic agent in the treatment of myocardial infarction.  Circulation.  96:2647-2647. 1997
  • Evaluation of atrioventricular valve abnormalities using real-time three-dimensional echocardiography.  Circulation.  96:1045-1045. 1997
  • Functional outcome of CABG in the elderly.  Circulation.  96:2066-2066. 1997
  • Gene transfer of superoxide dismutase reduces superoxide anion but does not improve endothelial dependent relaxation in atherosclerosis.  Circulation.  96:956-956. 1997
  • Impact of contrast media on clinical outcomes following percutaneous coronary interventions with platelet glycoprotein IIb/IIIa inhibition: Meta-analysis of clinical trials with abciximab.  Circulation.  96:898-898. 1997
  • In situ visualization of reactive oxygen species in atherosclerosis.  Circulation.  96:2323-2323. 1997
  • In-lab angiographic complications during coronary intervention with abciximab vs placebo in the EPILOG trial.  Circulation.  96:905-905. 1997
  • International differences in outcomes: Results from the GUSTO-III trial.  Circulation.  96:1118-1118. 1997
  • Ionic, low osmolar contrast is associated with better outcome following direct PTCA: Results from GUSTO-IIb.  Circulation.  96:2978-2978. 1997
  • Level of beta ARK1 regulates myocardial contractile function in gene targeted mice.  Circulation.  96:1632-1632. 1997
  • Loss of anticoagulant activity of heparan sulfate proteoglycans in porcine to human xenotransplantation.  Circulation.  96:3161-3161. 1997
  • Nearly half of early benefit of direct angioplasty lost in longer term follow-up: 6-month results from the GUSTO-IIb direct angioplasty substudy.  Circulation.  96:1137-1137. 1997
  • Normal skeletal muscle contractile function in patients with chronic heart failure.  Circulation.  96:1785-1785. 1997
  • Passive acoustic imaging: A new non-invasive method for detecting coronary artery stenosis change following percutaneous intervention.  Circulation.  96:3293-3293. 1997
  • Percutaneous interventional outcomes in octagenarians: Insights from the National Cardiovascular Network database.  Circulation.  96:53-53. 1997
  • Racial differences in the management of unstable angina: Results from the GUARANTEE registry.  Circulation.  96:3329-3329. 1997
  • Reciprocal regulation of myocardial beta ARK1 by beta adrenergic agonists and antagonists.  Circulation.  96:2773-2773. 1997
  • TIMI grade 3 flow after primary coronary angioplasty predicts both early and late survival following acute myocardial infarction.  Circulation.  96:2236-2236. 1997
  • Thrombomodulin activity in porcine-to-human xenotransplantation.  Circulation.  96:3163-3163. 1997
  • Tight control of aPTT in acute coronary syndrome patients using an automated strategy for bedside heparin adjustment: Results from the PARAGON A trial.  Circulation.  96:4200-4200. 1997
  • Transportability of CABG mortality models.  Circulation.  96:3789-3789. 1997
  • Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats - Comment.  Stroke.  28:615-616. 1997
  • Extension of the reliability of the NIH stroke, scale to non-neurologists.  Stroke.  28:23-23. 1997
  • Polymorphism in endoglin as a risk factor for intracerebral hemorrhage.  Stroke.  28:69-69. 1997
  • Adenovirus mediated gene transfer to isolated canine and human coronary conduit and resistance vessels.  Circulation.  94:1421-1421. 1996
  • Angiography: ''Gold'' standard or ''tin'' standard of reperfusion? A comparison with continuous 12-lead ST-segment recovery for prediction of clinical outcomes after thrombolytic therapy for acute myocardial infarction.  Circulation.  94:2572-2572. 1996
  • Blunted contractility in conscious transgenic mice overexpressing the G protein coupled receptor kinase-5.  Circulation.  94:2251-2251. 1996
  • Can you believe your risk-adjusted outcomes.  Circulation.  94:59-59. 1996
  • Constitutive nitric oxide release from vascular endothelial cells, cardiac myocytes and neurons.  Circulation.  94:2026-2026. 1996
  • Costs of direct angioplasty versus thrombolysis for acute myocardial infarction: Results from the GUSTO II randomized trial.  Circulation.  94:973-973. 1996
  • Desensitization of adenosine A1 receptors with cardiac overexpression of the G protein-coupled receptor kinase 5 in transgenic mice..  Circulation.  94:2375-2375. 1996
  • Development of a stress myocardial perfusion imaging model to predict cardiac death.  Circulation.  94:111-111. 1996
  • Do regional differences in invasive cardiac procedure hates drive costs of care for the acute myocardial infarction patient?.  Circulation.  94:2965-2965. 1996
  • Does interventional volume or academic status affect outcome? Insights from the IMPACT-II trial.  Circulation.  94:1888-1888. 1996
  • Does the use of noninvasive testing reduce short- and long-term cost of care?.  Circulation.  94:978-978. 1996
  • Echocardiography in patients with Staphylococcus aureus bacteremia.  Circulation.  94:1133-1133. 1996
  • Effect of glycoprotein IIb/IIIa receptor inhibition on specific in-lab complications of coronary intervention and resultant CKMB elevation in the IMPACT II trial.  Circulation.  94:1150-1150. 1996
  • Effect of platelet glycoprotein (GP) IIb/IIIa antagonism with integrilin on activated clotting times during coronary interventions: Results from the IMPACT II trial.  Circulation.  94:1148-1148. 1996
  • Examining the prognostic accuracy of exercise treadmill testing in 1,617 symptomatic women.  Circulation.  94:3307-3307. 1996
  • Femoral vascular complications following coronary intervention: Is mechanical clamp hemostasis better than hand pressure?.  Circulation.  94:2197-2197. 1996
  • Genetic manipulation of the beta-adrenergic receptor kinase (beta ARK1) modifies contractile response to beta(1)-adrenergic stimulation in single cardiac myocytes.  Circulation.  94:1676-1676. 1996
  • Human complement activation supports the induction of prothrombinase activity in a model of porcine to human xenotransplantation.  Circulation.  94:3712-3712. 1996
  • Impact of hirudin versus heparin on mortality and (re)infarction in patients with acute coronary syndromes: A prospective meta-analysis of the GUSTO-IIb and TIMI 9b trials.  Circulation.  94:2507-2507. 1996
  • Improving cost-effectiveness of coronary angioplasty in medically treated angina patients: The economic value of documenting myocardial ischemia.  Circulation.  94:4262-4262. 1996
  • Is the prognostic value of ST depression improved with heart rate adjustment?.  Circulation.  94:3314-3314. 1996
  • Lack of rebound recurrence of reinfarction after discontinuation of antithrombin therapy: Results from the GUSTO IIb trial.  Circulation.  94:2516-2516. 1996
  • Linkage of diastolic salt sensitivity in African Americans to the beta(2)-adrenergic receptor region of chromosome 5.  Circulation.  94:186-186. 1996
  • Long term survival after aortic or mitral valve operation in patients with left ventricular dysfunction.  Circulation.  94:3797-3797. 1996
  • Marked enhancement of clinical efficacy of platelet GP IIb/IIIa blockade with c7E3 fab (Abciximab) linked to reduction in bleeding complications: Outcome in the EPILOG and EPIC trials.  Circulation.  94:2185-2185. 1996
  • Mechanism of human coronary arteriolar relaxation to bradykinin.  Circulation.  94:1412-1412. 1996
  • National patterns of post-MI non-invasive testing in the elderly: Results in 190,237 patients..  Circulation.  94:2972-2972. 1996
  • Outcomes in patients treated with multiple coronary stents.  Circulation.  94:1931-1931. 1996
  • Platelet GP IIb/IIIa receptor blockade reduces ischemic complications in patients undergoing directional coronary atherectomy.  Circulation.  94:1154-1154. 1996
  • Practice patterns and outcomes amongst non ST elevation patients with acute coronary syndromes..  Circulation.  94:160-160. 1996
  • Pre-thrombolysis resolution of ST segment elevation identifies a low risk group in acute myocardial infarction.  Circulation.  94:2222-2222. 1996
  • Preferential nitroglycerin tolerance in the resistance coronary vasculature.  Circulation.  94:96-96. 1996
  • Prognostic value of transthoracic echo in the Duke cardiovascular disease database.  Circulation.  94:151-151. 1996
  • Prophylactic lidocaine use in GUSTO-I and GUSTO-II: Incidence and outcomes.  Circulation.  94:1143-1143. 1996
  • Protein kinase C dependent myogenic constriction of isolated human coronary arterioles.  Circulation.  94:2865-2865. 1996
  • Recurrent ischemia in the GUSTO IIb trial.  Circulation.  94:2225-2225. 1996
  • Relationship between physician angioplasty volume and outcome in 97,000 elderly Americans.  Circulation.  94:3115-3115. 1996
  • Streptokinase and hirudin reduces death and reinfarction in acute myocardial infarction compared with streptokinase and heparin: Results from GUSTO IIb.  Circulation.  94:2509-2509. 1996
  • Temporal trends in the process of myocardial infarction management; Canadian/US GUSTO experience..  Circulation.  94:158-158. 1996
  • The global unstable angina registry and treatment evaluation (GUARANTEE) study.  Circulation.  94:1136-1136. 1996
  • Thrombomodulin activity in isolated blood vessels: Vascular distribution, species specificity and implications for porcine to human xenotransplantation..  Circulation.  94:3713-3713. 1996
  • Clinical and radiographic factors associated with mortality following intracranial hemorrhage after thrombolysis for acute myocardial infarction.  Stroke.  27:90-90. 1996
  • Effect of ApoE genotype and age on survival after intracerebral hemorrhage.  Stroke.  27:94-94. 1996
  • National survey of stroke prevention practices: Surgical management.  Stroke.  27:32-32. 1996
  • 5-YEAR OUTCOME AFTER CORONARY SURGERY OR CORONARY ANGIOPLASTY - RESULTS FROM THE EMORY ANGIOPLASTY VS SURGERY TRIAL (EAST).  Circulation.  92:2594-2594. 1995
  • ACTIVATED PARTIAL THROMBOPLASTIN TIME AND CLINICAL OUTCOME AMONG PATIENTS WITH UNSTABLE ANGINA OR NON-Q-WAVE MI TREATED WITH INTRAVENOUS HEPARIN.  Circulation.  92:1985-1985. 1995
  • ADENOVIRUS-MEDIATED GENE-TRANSFER POTENTIATES BETA-ADRENERGIC SIGNALING IN ADULT-RABBIT VENTRICULAR MYOCYTES.  Circulation.  92:2396-2396. 1995
  • BASAL TONE OF ISOLATED HUMAN CORONARY ARTERIOLES DEPENDS ON PROTEIN-KINASE-C ACTIVATION.  Circulation.  92:2053-2053. 1995
  • BENEFICIAL IMPACT OF A PLATELET INHIBITOR, INTEGRELIN, ON PARAMETERS OF CONTINUOUS 12-LEAD ST-SEGMENT RECOVERY DURING MYOCARDIAL INFRACTION.  Circulation.  92:1984-1984. 1995
  • CAN CLINICAL FACTORS EXPLAIN VARIATIONS IN LENGTH OF STAY FOLLOWING CORONARY-ARTERY BYPASS-SURGERY - RESULTS OF THE COOPERATIVE CARDIOVASCULAR PROJECT.  Circulation.  92:2084-2084. 1995
  • DIABETIC-RETINOPATHY SHOULD NOT BE A CONTRAINDICATION TO THROMBOLYTIC THERAPY - QUANTIFICATION OF RISK IN 6011 PATIENTS.  Circulation.  92:1986-1986. 1995
  • DOES A CONSERVATIVE POST-MI CATHETERIZATION STRATEGY MISS SEVERE CORONARY-DISEASE - COMPARISONS OF USE AND DIAGNOSTIC YIELD IN CANADA AND THE US.  Circulation.  92:565-565. 1995
  • DOPPLER DETERMINATION OF LEFT-VENTRICULAR DIASTOLIC DYSFUNCTION PREDICTS OUTCOME IN NEONATAL CONGENITAL HEART-DISEASE FOLLOWING REPAIR OR PALLIATION.  Circulation.  92:2781-2781. 1995
  • DURATION OF TREATMENT NECESSARY TO PREVENT SYMPTOM RECURRENCE IN YOUNG-PATIENTS WITH NEUROCARDIOGENIC SYNCOPE.  Circulation.  92:3677-3677. 1995
  • HEMORRHAGIC NON-CNS COMPLICATIONS ASSOCIATED WITH 4 THROMBOLYTIC STRATEGIES FOR ACUTE MYOCARDIAL-INFARCTION.  Circulation.  92:2197-2197. 1995
  • INTENSITY OF INHIBITION OF THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR DIFFERS AMONG DISEASE STATES.  Circulation.  92:2333-2333. 1995
  • INTERVENTIONS MAY NOT BE NECESSARY IN ACUTE MYOCARDIAL-INFARCTION (MI) PATIENTS WITH LESS-THAN-OR-EQUAL-TO-200 UV ST-SEGMENT ELEVATION, IRRESPECTIVE OF INFARCT ARTERY PATENCY.  Circulation.  92:3557-3557. 1995
  • LONG-TERM FOLLOW-UP IN PATIENTS WITH ABNORMAL THALLIUM SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY (SPECT) AND NORMAL CORONARY-ARTERIES.  Circulation.  92:1361-1361. 1995
  • LONG-TERM SURVIVAL AFTER MYOCARDIAL-INFARCTION IN PATIENTS WITH MULTIVESSEL CORONARY-DISEASE - A COMPARISON OF INFARCT-RELATED ARTERY (IRA) REVASCULARIZATION VERSUS TOTAL REVASCULARIZATION (TR).  Circulation.  92:356-356. 1995
  • MECHANISM OF HUMAN CORONARY ARTERIOLAR RELAXATION TO ADENOSINE-DIPHOSPHATE.  Circulation.  92:621-621. 1995
  • NON-Q VS Q-WAVE MYOCARDIAL-INFARCTION POST-THROMBOLYSIS - ANGIOGRAPHIC INSIGHTS.  Circulation.  92:2529-2529. 1995
  • PHOSPHORYLATION AND DESENSITIZATION OF ENDOTHELIN RECEPTOR TYPE-A AND TYPE-B BY G-PROTEIN-COUPLED RECEPTOR KINASES.  Circulation.  92:1761-1761. 1995
  • PLATELET GLYCOPROTEIN-IIB/GLYCOPROTEIN-IIIA INHIBITION WITH INTEGRELIN(TM) DURING PERCUTANEOUS CORONARY INTERVENTION - THE IMPACT-II TRIAL.  Circulation.  92:2595-2595. 1995
  • PREDICTING MORTALITY FOLLOWING CORONARY ANGIOPLASTY - RESULTS FROM THE COOPERATIVE CARDIOVASCULAR PROJECT.  Circulation.  92:2274-2274. 1995
  • PREDICTING MORTALITY FOLLOWING CORONARY-BYPASS SURGERY IN THE ELDERLY - RESULTS FROM THE COOPERATIVE CARDIOVASCULAR PROJECT.  Circulation.  92:3088-3088. 1995
  • PROGNOSTIC-SIGNIFICANCE OF POST-INTERVENTION ISOZYME ELEVATIONS.  Circulation.  92:2599-2599. 1995
  • QUANTITATIVE THALLIUM SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY PREDICTS RISK FOR POOR OUTCOME IN THE EMORY ANGIOPLASTY SURGERY TRIAL.  Circulation.  92:2487-2487. 1995
  • RANDOMIZED TRIAL OF PLATELET GLYCOPROTEIN-IIB/GLYCOPROTEIN-IIIA INHIBITION WITH INTEGRELIN(TM) FOR PREVENTION OF RESTENOSIS FOLLOWING CORONARY INTERVENTION - THE IMPACT-II ANGIOGRAPHIC SUBSTUDY.  Circulation.  92:2905-2905. 1995
  • REINFARCTION FOLLOWING DISCONTINUATION OF INTRAVENOUS HEPARIN OR HIRUDIN FOR UNSTABLE ANGINA AND ACUTE MYOCARDIAL-INFARCTION.  Circulation.  92:2196-2196. 1995
  • RISK-FACTORS AND OUTCOMES IN PATIENTS WITH ATRIAL-FIBRILLATION FOLLOWING ACUTE MYOCARDIAL-INFARCTION.  Circulation.  92:3740-3740. 1995
  • SURVIVAL FOLLOWING ACUTE MYOCARDIAL-INFARCTION ACCORDING TO PHYSICIAN SPECIALTY.  Circulation.  92:564-564. 1995
  • THE DUKE TREADMILL SCORE IS AN ACCURATE PREDICTOR OF THE EXTENT OF CORONARY-ARTERY DISEASE AND 5-YEAR SURVIVAL.  Circulation.  92:1287-1287. 1995
  • TRANSGENIC MICE WITH CARDIAC-SPECIFIC EXPRESSION OF A CONSTITUTIVELY ACTIVE BETA-2-ADREGENIC RECEPTOR.  Circulation.  92:196-196. 1995
  • UNDERUTILIZATION OF AORTIC COUNTERPULSATION IN PATIENTS WITH CARDIOGENIC-SHOCK - OBSERVATIONS FROM THE GUSTO-1 STUDY.  Circulation.  92:658-658. 1995
  • ASSOCIATION BETWEEN ESSENTIAL-HYPERTENSION IN BLACKS AND BETA(2)-ADRENERGIC RECEPTOR GENOTYPE.  Hypertension.  26:575-575. 1995
  • MACROVASCULAR AND MICROVASCULAR ASSESSMENT OF ACUTE STROKE USING TCD AND GADOLINIUM-DTPA MR PERFUSION IMAGING - A COMPARATIVE-STUDY.  Stroke.  26:729-729. 1995
  • IDENTIFICATION OF PERFUSION PENUMBRA IN ACUTE MIDDLE CEREBRAL ARTERIAL STROKE BY GADOLINIUM-DTPA MRI.  Stroke.  26:180-180. 1995
  • US NATIONAL SURVEY OF PHYSICIAN PRACTICES FOR STROKE PREVENTION.  Stroke.  26:161-161. 1995
  • EFFECT OF AGING ON CEREBRAL AUTOREGULATION DURING CARDIOPULMONARY BYPASS - ASSOCIATION WITH POSTOPERATIVE COGNITIVE DYSFUNCTION.  Circulation.  90:243-249. 1994
  • ALLOXAN-INDUCED DIABETES-MELLITUS IMPAIRS ENDOTHELIUM-DEPENDENT VASODILATION OF CANINE CORONARY ARTERIOLES.  Circulation.  90:430-430. 1994
  • ARTERIOGRAPHICALLY DEFINED REASONS FOR ADDITIONAL PROCEDURES IN EAST.  Circulation.  90:60-60. 1994
  • BEDSIDE APTT MONITORING IS ASSOCIATED WITH LESS BLEEDING AMONG GUSTO PATIENTS RECEIVING IV HEPARIN FOLLOWING THROMBOLYTIC ADMINISTRATION.  Circulation.  90:553-553. 1994
  • CAN DISEASE SEVERITY EXPLAIN RACIAL VARIATION IN REVASCULARIZATION USE.  Circulation.  90:45-45. 1994
  • CARDIAC MUSCARINIC K+ CHANNEL ACTIVITY IS SUPPRESSED BY A G-PROTEIN BETA-GAMMA-PEPTIDE INHIBITOR.  Circulation.  90:525-525. 1994
  • DESENSITIZATION OF THE BETA-ADRENERGIC-RECEPTOR BY RECEPTOR-SPECIFIC KINASES.  Circulation.  90:358-358. 1994
  • DISCORDANCE BETWEEN ANGIOGRAPHIC PATENCY AND ST-SEGMENT RECOVERY, IN ACUTE MYOCARDIAL-INFARCTION - IS IT TIME TO RETHINK THE GOLD STANDARD.  Circulation.  90:220-220. 1994
  • ELECTROCARDIOGRAPHIC DIAGNOSIS OF IMPENDING ACUTE MYOCARDIAL-INFARCTION IN THE PRESENCE OF LEFT-BUNDLE-BRANCH BLOCK - OBSERVATIONS FROM GUSTO.  Circulation.  90:444-444. 1994
  • ESTABLISHMENT OF TRANSGENIC MICE WITH CARDIAC-SPECIFIC EXPRESSION OF THE BETA-ADRENERGIC-RECEPTOR KINASE AND AN INHIBITOR OF THIS KINASE.  Circulation.  90:304-304. 1994
  • HEPARIN DURING CORONARY ANGIOPLASTY - ARE THERE ANY RULES.  Circulation.  90:487-487. 1994
  • INFLUENCE OF EPICARDIAL PATCHES ON DEFIBRILLATION THRESHOLD USING NONTHORACOTOMY LEAD CONFIGURATIONS.  Circulation.  90:123-123. 1994
  • OUTCOMES OF CORONARY-BYPASS SURGERY IN US OCTOGENARIANS.  Circulation.  90:530-530. 1994
  • REDEFINING UNCOMPLICATED MYOCARDIAL-INFARCTION IN THE THROMBOLYTIC ERA.  Circulation.  90:110-110. 1994
  • THE HIGH-RISK MYOCARDIAL-ISCHEMIA TRIAL (HIRMIT) RANDOMIZED PILOT AND REGISTRY - 6 DAY, 6 WEEK, 6 MONTH AND 1 YEAR MORTALITY.  Circulation.  90:334-334. 1994
  • UNEXPLAINED VARIATION IN RESOURCE USE FOR CORONARY-BYPASS GRAFT-SURGERY.  Circulation.  90:92-92. 1994
  • UNIVARIATE RELATIONSHIPS BETWEEN MORTALITY AND PARAMETERS OF CONTINUOUS 12-LEAD ST-SEGMENT DEVIATION AND RECOVERY AFTER THROMBOLYTIC THERAPY FOR ACUTE INFARCTION.  Circulation.  90:501-501. 1994
  • GENETIC-ASPECTS OF INTRACRANIAL ANEURYSMS AND SAH.  Stroke.  25:257-257. 1994
  • RISK OF INTRACRANIAL ANEURYSMS IN FAMILIES WITH SUBARACHNOID HEMORRHAGE.  Stroke.  25:248-248. 1994
  • ACETYLCHOLINE CONSTRICTS ISOLATED HUMAN CORONARY RESISTANCE VESSELS.  Circulation.  88:374-374. 1993
  • ACTIVE WITHDRAWAL OF SUPPORT - EFFECT OF THE PATIENT SELF-DETERMINATION ACT ON THE CORONARY-CARE UNIT.  Circulation.  88:337-337. 1993
  • AORTIC-VALVE REPLACEMENT AFTER BALLOON AORTIC VALVULOPLASTY IN THE ELDERLY.  Circulation.  88:574-574. 1993
  • CARDIAC COMPRESSION SIGNIFICANTLY IMPROVES DEFIBRILLATION EFFICACY.  Circulation.  88:592-592. 1993
  • COMPARISON OF CONTINUOUS ST-SEGMENT RECOVERY ANALYSIS WITH STATIC ECG METHODS FOR NONINVASIVE PATENCY ASSESSMENT IN ACUTE MYOCARDIAL-INFARCTION.  Circulation.  88:306-306. 1993
  • COMPARISON OF METHODS FOR DETERMINING THE UPPER LIMIT OF VULNERABILITY.  Circulation.  88:593-593. 1993
  • DEFIBRILLATION THRESHOLD MEASUREMENTS USING AN ENDOCARDIAL LEAD CONFIGURATION WITH AND WITHOUT INACTIVE EPICARDIAL PATCH IN DOGS.  Circulation.  88:592-592. 1993
  • EFFECTS OF PEAK ST DEVIATION AND INFARCT ARTERY LOCATION ON ACCURACY OF PATENCY ASSESSMENT BY CONTINUOUS ST-SEGMENT RECOVERY ANALYSIS IN THE GUSTO TRIAL.  Circulation.  88:258-258. 1993
  • EFFECTS OF S-NITROSO-ALBUMIN AND NITROGLYCERIN ON CORONARY CONDUCTANCE AND FLOW REGULATORY VESSELS.  Circulation.  88:34-34. 1993
  • EXCIMER LASER-FACILITATED ANGIOPLASTY FOR UNDILATABLE CORONARY LESIONS - RESULTS OF A PROSPECTIVE CONTROLLED-STUDY.  Circulation.  88:24-24. 1993
  • IMPROVEMENT IN CLINICAL OUTCOMES OF CORONARY ANGIOPLASTY BY TREATMENT WITH THE GPIIB/IIIA INHIBITOR CHIMERIC-7E3 - MULTIVARIABLE ANALYSIS OF THE EPIC STUDY.  Circulation.  88:506-506. 1993
  • INCOMPLETE REVASCULARIZATION AT ANGIOPLASTY LIMITS THE USEFULNESS OF FOLLOW-UP EXERCISE TESTING IN PREDICTING RESTENOSIS.  Circulation.  88:64-64. 1993
  • ISOLATED HUMAN CORONARY ARTERIOLES EXHIBIT MYOGENIC TONE.  Circulation.  88:471-471. 1993
  • OUTCOME OF PATIENTS TREATED WITH THE GPIIB/IIIA INHIBITOR INTEGRELIN DURING CORONARY ANGIOPLASTY - RESULTS OF THE IMPACT STUDY.  Circulation.  88:595-595. 1993
  • PERCUTANEOUS EXCIMER-LASER CORONARY ANGIOPLASTY WITH ECCENTRIC MONORAIL CATHETERS.  Circulation.  88:24-24. 1993
  • PLATELET-FUNCTION DURING INTEGRELIN ADMINISTRATION IN CORONARY ANGIOPLASTY.  Circulation.  88:319-319. 1993
  • PRELOAD RECRUITABLE STROKE WORK - INSENSITIVE TO AFTERLOAD IN THE FALLING HEART.  Circulation.  88:244-244. 1993
  • SIMULTANEOUS HOLTER, VCG, AND ECG ST-MONITORING DURING TRANSIENT OCCLUSION AND REPERFUSION - IMPLICATIONS FOR COMPARING OR COMBINING DATA SETS.  Circulation.  88:306-306. 1993
  • THE CHANGING PROFILE OF PATIENTS AND LESIONS TREATED WITH PERCUTANEOUS EXCIMER-LASER CORONARY ANGIOPLASTY - 1989 TO 1993.  Circulation.  88:23-23. 1993
  • THE RELATIONSHIP BETWEEN ANGIOPLASTY VOLUME AND OUTCOME IN THE ELDERLY IN THE MEDICARE DATABASE.  Circulation.  88:480-480. 1993
  • UPTAKE MECHANISMS OF I-123 METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) IN ISOLATED RAT-HEART.  Circulation.  88:355-355. 1993
  • OBSERVATIONAL COMPARISON OF EVENT-FREE SURVIVAL WITH MEDICAL AND SURGICAL THERAPY IN PATIENTS WITH CORONARY-ARTERY DISEASE - 20 YEARS OF FOLLOW-UP.  Circulation.  86:198-204. 1992
  • ACUTE COMPLICATIONS OF CORONARY EXCIMER LASER ANGIOPLASTY - ANALYSIS OF 2 MULTICENTER REGISTRIES.  Circulation.  86:510-510. 1992
  • AN OVERVIEW OF THE EFFECT OF INTRAVENOUS HEPARIN ON CLINICAL END-POINTS FOLLOWING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION.  Circulation.  86:259-259. 1992
  • APTTS AFTER THROMBOLYSIS AND STANDARD INTRAVENOUS HEPARIN ARE OFTEN LOW AND CORRELATE WITH BODY-WEIGHT, AGE AND SEX - EXPERIENCE FROM THE GUSTO TRIAL.  Circulation.  86:258-258. 1992
  • DETECTION OF RECURRENT ISCHEMIA WITH CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING - EARLY RISK STRATIFICATION FOLLOWING THROMBOLYTIC THERAPY.  Circulation.  86:136-136. 1992
  • DOES FOLLOW-UP EXERCISE TESTING PREDICT RESTENOSIS AFTER SUCCESSFUL ANGIOPLASTY.  Circulation.  86:137-137. 1992
  • E1A-MEDIATED INHIBITION OF MYOGENESIS - A DIRECT PHYSICAL INTERACTION OF E1A(12S) AND BHLH PROTEINS.  Circulation.  86:347-347. 1992
  • IN-HOSPITAL TREATMENT DELAYS IN PATIENTS TREATED WITH THROMBOLYTIC THERAPY - A REPORT OF THE GUSTO TIME TO TREATMENT SUBSTUDY.  Circulation.  86:702-702. 1992
  • INCREASED CORONARY PERFORATION IN THE NEW DEVICE ERA - INCIDENCE, CLASSIFICATION, MANAGEMENT AND OUTCOME.  Circulation.  86:787-787. 1992
  • INFLUENCE OF GENDER ON REFERRAL TO CARDIAC-CATHETERIZATION - PHYSICIAN BIAS OR APPROPRIATE MANAGEMENT.  Circulation.  86:38-38. 1992
  • INTRACORONARY ULTRASOUND EVALUATION OF EXCIMER LASER ANGIOPLASTY.  Circulation.  86:516-516. 1992
  • NONINVASIVE DETECTION OF REPERFUSION AFTER THROMBOLYSIS BASED ON CLINICAL-ASSESSMENT AND RAPID CK-MB ANALYSIS.  Circulation.  86:268-268. 1992
  • OXYGEN DEPENDENT INCREASES IN HYDROXYL RADICAL (OH.) PRODUCTION IN CYTOSOL AND MITOCHONDRIA IN BRAIN ISCHEMIA-REPERFUSION.  Circulation.  86:68-68. 1992
  • POOLED ANALYSIS OF ANGIOGRAPHIC PATENCY RATES FROM THROMBOLYTIC THERAPY TRIALS.  Circulation.  86:269-269. 1992
  • PREDISCHARGE EXERCISE TESTING DOES NOT PREDICT CLINICAL EVENTS OR RESTENOSIS AFTER SUCCESSFUL ANGIOPLASTY.  Circulation.  86:137-137. 1992
  • RISK OF CORONARY-ARTERY PERFORATION DURING EXCIMER LASER ANGIOPLASTY.  Circulation.  86:654-654. 1992
  • TREATMENT OF AORTOOSTIAL DISEASE WITH PERCUTANEOUS EXCIMER LASER CORONARY ANGIOPLASTY.  Circulation.  86:512-512. 1992
  • RECOVERY OF CEREBRAL METABOLISM AND MITOCHONDRIAL OXIDATION-STATE IS DELAYED AFTER HYPOTHERMIC CIRCULATORY ARREST.  Circulation.  84:400-406. 1991
  • CLINICAL-EVALUATION OF SINGLE VERSUS MULTIPLE MAMMARY ARTERY BYPASS.  Circulation.  82:214-223. 1990
  • BARRESTIN - A NOVEL PROTEIN THAT REGULATES BETA-ADRENERGIC-RECEPTOR FUNCTION.  Circulation.  82:LR3-LR3. 1990
  • BRAIN METABOLISM AND CYTOCHROME OXIDATION ARE IMPAIRED AFTER HYPOTHERMIC CIRCULATORY ARREST IN CHILDREN.  Circulation.  82:412-412. 1990
  • CAN INTRACORONARY UROKINASE SALVAGE VESSEL PATENCY AFTER FAILED INTRAVENOUS-TPA AND PREVENT THE NEED FOR RESCUE PTCA.  Circulation.  82:537-537. 1990
  • CONDITIONAL PROBABILITIES OF RESTENOSIS FOLLOWING CORONARY ANGIOPLASTY.  Circulation.  82:1-1. 1990
  • DETERMINANTS OF EARLY VS LATE CARDIAC DEATH IN PATIENTS UNDERGOING CORONARY-ARTERY BYPASS (CAB).  Circulation.  82:506-506. 1990
  • EARLY AND LATE OUTCOME FOLLOWING CORONARY TRANSLUMINAL EXTRACTION-ENDARTERECTOMY - A MULTICENTER EXPERIENCE.  Circulation.  82:310-310. 1990
  • EFFECTS OF AMIODARONE ON MYOCARDIAL ENERGY-METABOLISM DURING ISCHEMIA.  Circulation.  82:145-145. 1990
  • EFFECTS OF CHRONIC LEFT-VENTRICULAR FAILURE ON MYOCARDIAL ENERGETICS IN THE CONSCIOUS DOG.  Circulation.  82:566-566. 1990
  • EFFECTS OF UNSTABLE SYMPTOMS ON RESTENOSIS.  Circulation.  82:427-427. 1990
  • HOSTILITY LEVELS AT AGE-19 PREDICT LIPID RISK PROFILES AT AGE-42.  Circulation.  82:228-228. 1990
  • INCOMPLETE ANGIOGRAPHIC FOLLOW-UP RESULTS IN SIGNIFICANT UNDERESTIMATION OF TRUE RESTENOSIS RATES AFTER PTCA.  Circulation.  82:312-312. 1990
  • OPTIMIZATION OF LONG-TERM OUTCOME IN ACUTE MITRAL REGURGITATION DUE TO MYOCARDIAL-INFARCTION.  Circulation.  82:511-511. 1990
  • ORAL-CONTRACEPTIVE USAGE AFFECTS CARDIOVASCULAR-RESPONSES IN LOW HOSTILE WOMEN.  Circulation.  82:577-577. 1990
  • PROSPECTIVE BLINDED NONINVASIVE DETECTION OF FAILED THROMBOLYSIS USING DIGITAL TRENDING FROM CONTINUOUS 12-LEAD ST-SEGMENT MONITORING.  Circulation.  82:254-254. 1990
  • THE IMPACT OF GENDER AND MENOPAUSAL STATUS ON RESTENOSIS AFTER ANGIOPLASTY.  Circulation.  82:624-624. 1990
  • TRANS-INACTIVATION OF THE MYOGLOBIN MUSCLE-SPECIFIC ENHANCER BY THE TRANSCRIPTIONAL REPRESSOR GCF.  Circulation.  82:106-106. 1990
  • EFFECT OF ANGIOPEPTIN ON ATHEROGENESIS IN CYNOMOLGOUS MACAQUES.  Arteriosclerosis (Dallas, Tex.).  10:A815-A815. 1990
  • FIBRIN MODIFICATION BY CONTRAST-MEDIA DURING CARDIAC-CATHETERIZATION.  Arteriosclerosis (Dallas, Tex.).  10:A928-A928. 1990
  • DRUGS INFLUENCE THE RECOVERY OF FUNCTION AFTER STROKE.  Stroke.  21:179-179. 1990
  • CHANGING EFFICACY OF CORONARY REVASCULARIZATION - IMPLICATIONS FOR PATIENT SELECTION.  Circulation.  78:185-191. 1988
  • CURRENT PROGNOSIS OF ISCHEMIC MITRAL REGURGITATION - IMPLICATIONS FOR FUTURE MANAGEMENT.  Circulation.  78:51-59. 1988
  • SPHINGOSINE INHIBITS TISSUE FACTOR-INDUCED BLOOD-CLOTTING.  Arteriosclerosis (Dallas, Tex.).  8:A664-A664. 1988
  • THE CHANGING SURVIVAL BENEFITS OF CORONARY REVASCULARIZATION OVER TIME.  Circulation.  76:13-21. 1987
  • THE ADRENERGIC-RECEPTORS.  Circulation.  76:A-A. 1987
  • THE EVOLUTION OF MEDICAL AND SURGICAL THERAPY FOR CORONARY-DISEASE - A 15 YEAR PERSPECTIVE.  Circulation.  76:350-350. 1987
  • ATRIOPEPTIN AND HYPERBARIC-INDUCED DIURESIS.  Circulation.  74:440-440. 1986
  • CHANGING SURVIVAL BENEFITS OF CORONARY REVASCULARIZATION OVER TIME.  Circulation.  74:308-308. 1986
  • DOPPLER-DERIVED INDEXES OF DIASTOLIC FILLING IN MILD TO MODERATE HYPERTENSION.  Circulation.  74:47-47. 1986
  • HOMOLOGY BETWEEN THE HUMAN AND HAMSTER BETA-2-ADRENERGIC RECEPTORS AND RHODOPSIN REVEALED BY MOLECULAR-CLONING.  Circulation.  74:155-155. 1986
  • TRANSLOCATION OF THE BETA-ADRENERGIC-RECEPTOR KINASE - THE KINASE ACTS ON MULTIPLE ADENYLATE-CYCLASE COUPLED RECEPTORS.  Circulation.  74:G-G. 1986
  • ANTIBODIES AGAINST A SYNTHETIC PEPTIDE RECOGNIZE THE BETA-ADRENERGIC-RECEPTOR.  Circulation.  72:183-183. 1985
  • DIFFERENCES IN THE CARBOHYDRATE CHAINS OF MAMMALIAN BETA-1-ADRENERGIC AND BETA-2-ADRENERGIC RECEPTORS.  Circulation.  70:68-68. 1984
  • MOLECULAR-BIOLOGY OF ADRENERGIC-RECEPTORS IN THE RAT AND FROG CENTRAL NERVOUS-SYSTEM.  Hypertension.  6:22-27. 1984
  • PULMONARY CIRCULATORY RESPONSES TO EXERCISE AT SEA-LEVEL AND SIMULATED ALTITUDE.  Circulation.  70:32-32. 1984
  • REGULATION OF BLOOD-FLOW IN EXPERIMENTAL BRAIN-TUMORS.  Stroke.  15:193-193. 1984
  • THE MAMMALIAN BETA-ADRENERGIC-RECEPTOR - FUNCTIONAL INTEGRITY OF THE RECEPTOR MOLECULE AFTER INVIVO DESENSITIZATION.  Circulation.  70:110-110. 1984
  • DIFFERENTIAL-EFFECTS OF ANTERIOR VERSUS INFERIOR ISCHEMIA ON GLOBAL RADIONUCLIDE EJECTION FRACTION - EFFECTS OF PHOTON ATTENUATION.  Circulation.  68:207-207. 1983
  • INVITRO SENSITIZATION OF TURKEY ERYTHROCYTE ADENYLATE-CYCLASE BY BETA-ADRENERGIC ANTAGONISTS.  Circulation.  68:98-98. 1983
  • CHARACTERIZATION OF AN AFFINITY ADSORBANT FOR HUMAN-PLATELET ALPHA-2-ADRENERGIC RECEPTORS.  Circulation.  66:72-72. 1982
  • DIRECT IDENTIFICATION OF BETA-1 AND BETA-2 ADRENERGIC-RECEPTORS IN HUMAN LEFT-VENTRICULAR MYOCARDIUM.  Circulation.  66:207-207. 1982
  • ANALYSES OF REGIONAL VARIATIONS IN ISCHEMIC-HEART-DISEASE MORTALITY TRENDS.  Circulation.  64:250-250. 1981
  • ELECTROCHEMICAL ANATOMY OF THE RABBIT RIGHT ATRIUM - POTASSIUM.  Circulation.  62:54-54. 1980
  • IMPROVED PREDICTIVE VALUE AND SPECIFICITY OF HEMOGLOBIN-AIC IN SCREENING FOR DIABETICS.  Circulation.  62:225-225. 1980
  • IS THE PREVALENCE OF HYPERTENSION OVERESTIMATED.  Circulation.  62:306-306. 1980
  • OUABAIN EFFECTS ON CONTRACTILE-FORCE AND INTRACELLULAR POTASSIUM ACTIVITY (ALPHA-KI).  Circulation.  62:282-282. 1980
  • POTASSIUM ACTIVITY IN RABBIT SINUS NODE.  Circulation.  62:54-54. 1980
  • REGULATION OF THE PLATELET ALPHA-2-ADRENERGIC RECEPTOR - DIFFERENTIAL-EFFECTS OF NA+ AND GUANINE-NUCLEOTIDES.  Circulation.  62:149-149. 1980
  • THYROID-HORMONE MODULATION OF AGONIST-BETA-ADRENERGIC RECEPTOR INTERACTIONS IN RAT MYOCARDIUM.  Circulation.  62:9-9. 1980
  • DETERMINATION OF ALPHA-ADRENERGIC RECEPTOR SUBTYPE SPECIFICITY BY RADIOLIGAND BINDING.  Circulation.  60:197-197. 1979
  • ISCHEMIC CONTRACTURE IN THE HYPERTROPHIED AND NORMAL CANINE LEFT-VENTRICLE.  Circulation.  60:115-115. 1979
  • INCREASED BETA-ADRENERGIC-RECEPTOR NUMBER IN RAT HEARTS AFTER CHEMICAL SYMPATHECTOMY OR PROPRANOLOL TREATMENT.  Circulation.  56:158-158. 1977
  • THYROID-HORMONE REGULATION OF BETA-ADRENERGIC-RECEPTOR NUMBER - POSSIBLE BIOCHEMICAL BASIS FOR HYPERADRENERGIC STATE IN HYPERTHYROIDISM.  Circulation.  56:166-166. 1977
  • DIRECT BINDING STUDIES OF SMOOTH-MUSCLE ALPHA-ADRENERGIC RECEPTORS USING [DIHYDROERGOCRYPTINE-H-3].  Circulation.  54:20-20. 1976
  • IDENTIFICATION AND CHARACTERIZATION OF BETA-ADRENERGIC RECEPTORS IN RAT-BRAIN BY (-) [H-3]ALPRENOLOL BINDING.  Circulation.  52:99-99. 1975
  • IDENTIFICATION OF CARDIAC BETA-ADRENERGIC-RECEPTOR BY STEREOSPECIFIC (-)[H-3]ALPRENOLOL BINDING.  Circulation.  52:24-24. 1975
  • MOLECULAR MECHANISM OF CATECHOLAMINE INDUCED DESENSITIZATION INVITRO.  Circulation.  52:25-25. 1975
  • REACTIVE HYPEREMIA IS CLOSELY ASSOCIATED WITH REPAYMENT OF MYOCARDIAL OXYGEN DEBT.  Circulation.  82:214-214. 1990
  • CARDIOPULMONARY INTERACTIONS - REPLY.  Circulation.  66:1348-1348. 1982
  • Adenoviral-mediated gene transfer of the beta(2)-adrenergic receptor improves function of the transplanted rat heart.  Circulation. 3744-3744. 1997
  • Comparison of open mitral commissurotomy to mitral valve replacement with or without chordal preservation in patients with mitral stenosis.  Circulation. 3822-3822. 1997
  • Human membrane cofactor protein (CD46) prevents hyperacute xenograft rejection in porcine-to-baboon cardiac xenotransplantation.  Circulation. 3167-3167. 1997
  • Novel determination of left ventricular volume by tracing arbitrary planes using real-time, 3D echocardiography: In vitro and in vivo validation.  Circulation. 1832-1832. 1997
  • Outcome of patients with prosthetic valve endocarditis diagnosed by Duke Criteria.  Circulation. 1165-1165. 1997
  • Tricuspid velocity profiles reflect right ventricular diastolic wall motion abnormalities: Real-time 3D echocardiography and computational fluid dynamics.  Circulation. 2990-2990. 1997
  • Bradykinin stimulates Ca2+ entry in rat cardiac fibroblasts which is necessary and sufficient for inhibition of collagen gene expression.  Hypertension. P138-P138. 1997
  • Bradykinin decreases mRNA levels for fibronectin and collagen via activation of intracellular Ca2+ mobilization and Ca2+ entry in cardiac fibroblasts..  Circulation. 4168-4168. 1996
  • Digital geometric models using biventricular real-time 3D echocardiography.  Circulation. 1230-1230. 1996
  • Discordant ventricular and myocardial efficiencies during aortic regurgitation in conscious dogs.  Circulation. 1701-1701. 1996
  • Functional effects of myocardial alpha-adrenergic receptor overexpression in transgenic mice..  Circulation. 2374-2374. 1996
  • Measurement of left ventricular volume by real-time, three-dimensional echocardiography in dogs.  Circulation. 2211-2211. 1996
  • More complete and stable reperfusion with platelet IIb/IIIa antagonism plus thrombolysis for AMI: The PARADIGM trial.  Circulation. 3232-3232. 1996
  • Quantitative assessment of LV ischemic risk volume using real time three-dimensional echocardiography.  Circulation. 4014-4014. 1996
  • Specific interactions between adrenergic receptors and receptor kinases in the hearts of hybrid transgenic mice.  Circulation. 2373-2373. 1996
  • ANGIOTENSIN II-MEDIATED CALCIUM SIGNALING IN CARDIAC FIBROBLASTS IS SPECIES-SPECIFIC.  Circulation. 302-302. 1995
  • DAMPENED CARDIAC-FUNCTION IN-VIVO IN TRANSGENIC MICE OVEREXPRESSING GRK5, A G-PROTEIN-COUPLED RECEPTOR KINASE.  Circulation. 1145-1145. 1995
  • MYOCARDIAL ENERGETICS DURING AORTIC REGURGITATION IN CONSCIOUS DOGS.  Circulation. 305-305. 1995
  • NONINVASIVE ASSESSMENT OF THE FRANK-STARLING RELATIONSHIP USING INTRAVENOUS VOLUME BOLUS AND 2-DIMENSIONAL ECHOCARDIOGRAPHY.  Circulation. 1285-1285. 1995
  • THE EFFECTS OF ISCHEMIA AND AGE ON MYOCARDIAL-FUNCTION IN HUMAN BETA-ADRENERGIC-RECEPTOR GENE OVEREXPRESSED HEARTS.  Circulation. 1113-1113. 1995
  • TREATMENT OF POSTOPERATIVE HYPERTENSION AFTER CORONARY-ARTERY BYPASS-SURGERY - DOUBLE-BLIND COMPARISON OF INTRAVENOUS ISRADIPINE AND SODIUM-NITROPRUSSIDE.  Circulation. 256-261. 1994
  • ADRENERGIC-RECEPTOR FUNCTION AND ENERGY PHOSPHATES IN BRAIN-DEATH RELATED CARDIAC DYSFUNCTION.  Circulation. 418-418. 1994
  • FINITE-ELEMENT ANALYSIS OF VENTRICULAR EJECTION.  Circulation. 12-12. 1994
  • GENERATION OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR THE TREATMENT OF POSTTRANSPLANT LYMPHOMA.  Circulation. 638-638. 1994
  • HEMODYNAMIC CONSEQUENCES OF PULSATILE SUPPORT ON PULMONARY ARTERIAL IMPEDANCE AND RIGHT-VENTRICULAR POWER.  Circulation. 309-309. 1994
  • THE EFFECTS OF VENTRICULAR PACING ON THE RELATIONSHIP BETWEEN LEFT-VENTRICULAR WORK OUTPUT AND MYOCARDIAL OXYGEN-CONSUMPTION IN CONSCIOUS DOGS.  Circulation. 483-483. 1994
  • THE RELATIONSHIP BETWEEN LEFT-VENTRICULAR WORK OUTPUT AND MYOCARDIAL OXYGEN-CONSUMPTION AFTER CHRONIC GLOBAL ISCHEMIC-INJURY IN CONSCIOUS DOGS.  Circulation. 483-483. 1994
  • USE OF INTRAVENOUS NITROGLYCERIN BOLUS AND 2-DIMENSIONAL ECHOCARDIOGRAPHY IN ASSESSMENT OF THE FRANK-STARLING RELATIONSHIP.  Circulation. 494-494. 1994
  • VALIDATION OF NEW DUKE CRITERIA FOR THE CLINICAL-DIAGNOSIS OF INFECTIVE ENDOCARDITIS - FOLLOW-UP OF REJECTED CASES.  Circulation. 120-120. 1994
  • VENTRICULAR HYPERTROPHY IN TRANSGENIC MICE WITH CARDIAC SPECIFIC OVEREXPRESSION OF A WILD-TYPE OR MUTANT ALPHA(1)-ADRENERGIC RECEPTOR.  Circulation. 304-304. 1994
  • LEFT-VENTRICULAR FILLING DYNAMICS - SIGMOIDAL PRESSURE-VOLUME RELATIONS.  Circulation. 57-57. 1993
  • LONG-TERM COSTS OF THERAPY FOR CAD - A PROSPECTIVE COMPARISON OF CORONARY ANGIOPLASTY, CORONARY-BYPASS SURGERY AND MEDICAL THERAPY IN 2258 PATIENTS.  Circulation. 480-480. 1993
  • RADIOFREQUENCY CATHETER MODIFICATION OF THE AV NODE FOR CONTROL OF RAPID VENTRICULAR RESPONSE TO ATRIAL-FIBRILLATION.  Circulation. 584-584. 1993
  • COMPARISON OF LEFT AND RIGHT VENTRICULAR COMPLIANCES.  Circulation. 726-726. 1992
  • EJECTION DYNAMICS AND SYSTOLIC LOAD DURING ARTERIAL VASODILATION.  Circulation. 461-461. 1992
  • HEART-RATE EFFECTS ON RIGHT AND LEFT-VENTRICULAR RELAXATION DYNAMICS.  Circulation. 529-529. 1992
  • PROGNOSIS AND MANAGEMENT OF ANTEROLATERAL MYOCARDIAL-INFARCTION IN PATIENTS WITH SEVERE LEFT MAIN DISEASE AND CARDIOGENIC-SHOCK.  Circulation. 437-437. 1992
  • THE INTERACTION OF MONOCYTES AND PLATELETS IN A CELL-BASED MODEL OF FACTOR-IX DEFICIENCY.  Circulation. 408-408. 1992
  • A PHORBOL ESTER ENHANCES BOTH BETA-1-ADRENOCEPTOR DOWN-REGULATION AND ADENYLYL CYCLASE ACTIVITY.  Circulation. 176-176. 1990
  • AMOUNT OF CHRONIC MI SPARING NEEDED FOR VENTRICULAR-TACHYCARDIA DUE TO LARGE-S2 STIMULI.  Circulation. 641-641. 1990
  • BLOOD CARDIOPLEGIA REPERFUSION - A RANDOMIZED STUDY OF VENTRICULAR RECOVERY AFTER ISCHEMIA.  Circulation. 589-589. 1990
  • COMPARISON OF HIGH AND LOW STRENGTH SHOCKS DELIVERED DURING VENTRICULAR-TACHYCARDIA IN DOGS.  Circulation. 549-549. 1990
  • DIABETES AS AN INDEPENDENT RISK FACTOR FOR SURVIVAL AFTER CORONARY-ARTERY BYPASS.  Circulation. 360-360. 1990
  • EFFECTS OF MULTIPLE INOTROPIC AGENTS ON MYOCARDIAL ENERGETICS IN THE CONSCIOUS DOG.  Circulation. 730-730. 1990
  • EVALUATION OF CORONARY-ARTERY BYPASS-GRAFTING WITH PERFUSION CONTRAST ECHOCARDIOGRAPHY.  Circulation. 97-97. 1990
  • INTRINSIC MYOCARDIAL PERFORMANCE IN VOLUME VS PRESSURE OVERLOAD HYPERTROPHY DURING PROSTHETIC VALVE-REPLACEMENT.  Circulation. 766-766. 1990
  • MYOCARDIAL WALL VOLUME AS AN INDEPENDENT DETERMINANT OF VENTRICULAR PERFORMANCE.  Circulation. 406-406. 1990
  • RECEPTOR CROSSTALK - EFFECTS OF CARBACHOL ON BETA-1-RECEPTORS AND ADENYLYL CYCLASE ACTIVITY.  Circulation. 176-176. 1990
  • THE EFFECT OF PHYSIOLOGICAL GROWTH ON LV-CHAMBER GEOMETRY AND INTRINSIC MYOCARDIAL PERFORMANCE.  Circulation. 152-152. 1990
  • COMPUTER-GENERATED IMAGE-ANALYSIS OF CAROTID ATHEROSCLEROSIS.  Arteriosclerosis (Dallas, Tex.). A710-A710. 1989
  • FIBRINOPEPTIDE-B AND INTIMAL THICKENING.  Arteriosclerosis (Dallas, Tex.). A702-A702. 1989
  • ATRIAL SEPTAL ANEURYSM - ASSOCIATION WITH CEREBROVASCULAR AND PERIPHERAL EMBOLIC EVENTS.  Circulation. 178-178. 1986
  • EFFECTS OF AFTERLOAD AND INOTROPIC STATE ON DIASTOLIC FUNCTION AFTER ISCHEMIC-INJURY.  Circulation. 71-71. 1985
  • EVALUATION OF THE VENA-CAVAL OCCLUSION TECHNIQUE FOR ASSESSING SYSTOLIC MYOCARDIAL PERFORMANCE.  Circulation. 86-86. 1985
  • RAPID DEPLETION OF MYOCARDIAL HIGH-ENERGY PHOSPHATES BY A SHORT-PERIOD OF VENTRICULAR-FIBRILLATION PRIOR TO CARDIOPLEGIC ARREST.  Circulation. 375-375. 1985
  • 3-DIMENSIONAL ANALYSIS OF STROKE WORK IN CONSCIOUS DOGS.  Circulation. 355-355. 1984
  • THE EFFECT OF SUPERFICIAL ENDOCARDIAL ABLATION ON VENTRICULAR-FIBRILLATION THRESHOLD.  Circulation. 224-224. 1984
  • THE END SYSTOLIC PRESSURE VOLUME RELATIONSHIP IN CONSCIOUS DOGS.  Circulation. 234-234. 1984
  • CONTINUOUS COMPUTER SURVEILLANCE OF CARDIAC-OUTPUT AFTER CORONARY-ARTERY BYPASS-GRAFTING.  Circulation. 251-251. 1983
  • DETERMINANTS OF CORONARY BLOOD-FLOW DURING EXTERNAL CARDIAC MASSAGE.  Circulation. 235-235. 1983
  • ELECTROPHYSIOLOGY OF NIFEDIPINE CARDIOPLEGIA - DOSE-RESPONSE RELATIONSHIPS.  Circulation. 184-184. 1983
  • HEMODYNAMIC-EFFECTS OF THE RIGHT VENTRICULAR ISOLATION PROCEDURE.  Circulation. 133-133. 1983
  • LINEARITY OF THE FRANK-STARLING RELATIONSHIP IN THE INTACT HEART.  Circulation. 371-371. 1983
  • RELATIONSHIP BETWEEN ALTERED DIASTOLIC PROPERTIES AND SYSTOLIC FUNCTION AFTER REVERSIBLE ISCHEMIC-INJURY.  Circulation. 253-253. 1983
  • TIA WITH BENIGN OUTCOME.  Stroke. 112-112. 1982
  • VENTRICULAR CRYOSURGERY - EFFECTS ON INTRAMURAL ELECTROPHYSIOLOGY AND METHODS TO CONTROL LESION SIZE.  Circulation. 89-89. 1981
  • ADAPTATION OF PULMONARY CIRCULATION TO ACUTE AND CHRONIC HIGH FLOW-STRESS.  Circulation. 81-81. 1978
  • RESPONSE OF PULMONARY CIRCULATION TO CHRONIC PULMONARY VENOUS HYPERTENSION.  Circulation. 81-81. 1978
  • EFFECT OF ELEVATED LEFT ATRIAL PRESSURE ON PULMONARY HEMODYNAMICS IN AWAKE DOG.  Circulation. 163-163. 1977